Not applicableStudy completedNCT05423730What this trial is testingAlcohol and Breast Cancer (ABC) TrialWho this might be right forER+ Breast CancerBreast CancerAromatase Inhibitors Beth Israel Deaconess Medical Center 23
Not applicableUnknownNCT03540979What this trial is testingEndometrial Preparation in Frozen Embryo Transfer CyclesWho this might be right forReproductive Behavior Meir Medical Center 100
Large-scale testing (Phase 3)Study completedNCT00333047What this trial is testingLetrozole in Metastatic Breast Cancer in Combination With ChemotherapyWho this might be right forMetastatic Breast Cancer Novartis 24
Large-scale testing (Phase 3)Study completedNCT00065325What this trial is testingThe Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast CancerWho this might be right forLocally Advanced Breast CancerMetastatic Breast Cancer AstraZeneca 694
Testing effectiveness (Phase 2)Study completedNCT02958852What this trial is testingA Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast CancerWho this might be right forBreast Cancer Lund University Hospital 126
Large-scale testing (Phase 3)Ended earlyNCT04869943What this trial is testingEfficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Veru Inc. 52
Testing effectiveness (Phase 2)Looking for participantsNCT07071038What this trial is testingEvaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer PatientsWho this might be right forBreast CancerAdjuvant TreatmentEarly Stage Breast Cancer Dartmouth-Hitchcock Medical Center 62
Not applicableStudy completedNCT01693731What this trial is testingOral Health in Breast Cancer Survivors on Aromatase InhibitorsWho this might be right forPeriodontal DiseaseQuality of Life University of Michigan 300
Not applicableUnknownNCT05098951What this trial is testingAcupuncture for Stiffness of Joint Related to Aromatase Inhibitors in Patients With Early-Stage Breast CancerWho this might be right forBreast CancerStiffness of Hand, Not Elsewhere Classified Affiliated Hospital of Qinghai University 52
Large-scale testing (Phase 3)Ended earlyNCT00908531What this trial is testingTrial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast CancerWho this might be right forOperable Breast Neoplasms Danish Breast Cancer Cooperative Group 123
Testing effectiveness (Phase 2)Study completedNCT01491737What this trial is testingPertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 258
Testing effectiveness (Phase 2)UnknownNCT01924078What this trial is testingCapecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast CancerWho this might be right forBreast Cancer Fudan University 100
Not applicableLooking for participantsNCT06606535What this trial is testingENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer PatientsWho this might be right forCognitive Side Effects of Cancer TherapyHypoestrogenism Ospedale Policlinico San Martino 60
Testing effectiveness (Phase 2)Study completedNCT03312738What this trial is testingEverolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase InhibitorWho this might be right forAdvanced Breast Cancer Novartis Pharmaceuticals 159
Testing effectiveness (Phase 2)Study completedNCT02866955What this trial is testingEvaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.Who this might be right forBreast Cancer Institut de Cancérologie de Lorraine 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT01984138What this trial is testingREVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor TherapyWho this might be right forEstrogen Receptor Positive Breast CancerBreast Cancer Polly A. Niravath, MD 33
Large-scale testing (Phase 3)Study completedNCT01610284What this trial is testingPhase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorWho this might be right forBreast Cancer Novartis Pharmaceuticals 1,147
Large-scale testing (Phase 3)Ended earlyNCT02730091What this trial is testingA Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced DiseaseWho this might be right forBreast Cancer Centre Hospitalier Universitaire de Besancon 98
Early research (Phase 1)Study completedNCT04080297What this trial is testingDose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or TamoxifenWho this might be right forVasomotor Symptoms (VMS) Que Oncology 21
Not applicableStudy completedNCT01951976What this trial is testingYoga for Aromatase Inhibitor-associated Joint PainWho this might be right forBreast Cancer H. Lee Moffitt Cancer Center and Research Institute 16